EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
EVIDARA:生物医学 KG 查询中中继代理的原始数据自动证据支持
基本信息
- 批准号:10330633
- 负责人:
- 金额:$ 43.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-24 至 2022-01-23
- 项目状态:已结题
- 来源:
- 关键词:AgreementArbitrationBudgetsCohort StudiesCommunicationConflict (Psychology)DataData SetEnsureGoalsInstitutionIntellectual PropertyJointsKnowledgeMedicalMultiomic DataNatureOffice of Administrative ManagementOutcomePersonsPhasePilot ProjectsPlayPrincipal InvestigatorPublicationsResearchResourcesRoleSystemTechnology TransferTestingWorkbasecohortcomputerized toolsdesignknowledge graphmembermultiple omicsnovelproduct developmentprograms
项目摘要
1. Rationale for the joint effort as a multi-PI (MPI) team. At the core of the is pilot project is the
combination of two sets of resources and expertise that each of the two principal investigators
(PIs), Dr. Sergio Baranzini (UCSF) and Dr. Sui Huang (ISB) will contribute to develop, test and
deliver a computational tool (“Automatic Relay Agent”, ARA) as defined by the FOA of Biomedical
Translator program of NCATS as a milestone for the “First Segment” (January- March, 2020). The
ARA envisioned by this team is EVIDARA, a system that extracts knowledge from a knowledge
graph (KG) and evaluates it against multi-omics raw data of a large cohort for evidential support.
The evidenced-tested knowledge is then relaying it to the Biomedical Translator. The two
resources that will be combined to build EVIDARA are: (i) A novel knowledge graph, SPOKE and
(ii) a new genre of multi-omics data sets from scientific wellness studies. The two PIs will bring
these two resources and thus play complementary role: Dr. Sergio Baranzini, with his team at
UCSF, is the developer of SPOKE and Dr. Sui Huang provides subject matter expertise in multiomics
studies and has access to data from a cohort studied at ISB that he has been analyzing.
Dr. Baranzini will bring expertise in all computational aspects of SPOKE and its new applications
and Dr. Huang will also act as subject matter expert in multi-omics driven medical practice and
research to guide product development and testing.
2. Goal of project and continuation. The pilot project id defined by the common goal of
delivering the milestone product, EVIDARA as described in the proposal. If the pilot project is
successful and this team is selected to continue to the “Second Segment” (an up to five project)
the two PIs will work again as an MPI team and jointly design the expansion of the project into
this second phase and jointly prepare the new research plan to NCATS.
3. Management and coordination. Dr. Huang, is the contact-MPI and will coordinate the project
and directly communicate with Dr. Baranzini to ensure that both MPIs are kept informed about
the project’s technical progress and all administrative matters. Each MPI will assume fiscal and
administrative management of their own team, as reflected in the budget and consortium
subcontract. Dr. Huang will be responsible for communication with NCATS Program manager
team. The two MPIs and their team members and institutional collaborators agree to work jointly
as a group towards the milestone product. Should publications result, both will be co-senior
authors and their team members included as authors based on their contribution, following
common academic practice. If there are any conflicts in the course of the project, both PIs and
collaborators will meet in person and work in a spirit of cooperation to resolve any conflicts. Given
that Drs. Huang and Baranzini have interacted academically for almost two decades, share the
same scholarly perspective and the complementary and synergistic nature of their expertise that
is required for the project it is highly unlikely a neutral arbitration committee would be required to
resolve conflicts.
4. Intellectual Property. For intellectual property issue, the Technology Transfer Offices at each
of the PI’s institutions will be responsible for agreements relating to the research and the outcome
of the work.
1. 作为多pi (MPI)团队共同努力的基本原理。该试点项目的核心是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SERGIO E BARANZINI其他文献
SERGIO E BARANZINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SERGIO E BARANZINI', 18)}}的其他基金
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
EVIDARA:生物医学 KG 查询中中继代理的原始数据自动证据支持
- 批准号:
10547256 - 财政年份:2020
- 资助金额:
$ 43.73万 - 项目类别:
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
EVIDARA:生物医学 KG 查询中中继代理的原始数据自动证据支持
- 批准号:
10706762 - 财政年份:2020
- 资助金额:
$ 43.73万 - 项目类别:
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
EVIDARA:生物医学 KG 查询中中继代理的原始数据自动证据支持
- 批准号:
10057190 - 财政年份:2020
- 资助金额:
$ 43.73万 - 项目类别:
The genetic basis of progression in multiple sclerosis
多发性硬化症进展的遗传基础
- 批准号:
10084323 - 财政年份:2017
- 资助金额:
$ 43.73万 - 项目类别:
The genetic basis of progression in multiple sclerosis
多发性硬化症进展的遗传基础
- 批准号:
9737736 - 财政年份:2017
- 资助金额:
$ 43.73万 - 项目类别:
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
GWAS 后方法可识别 MS 风险背后的细胞特异性遗传途径
- 批准号:
8925166 - 财政年份:2014
- 资助金额:
$ 43.73万 - 项目类别:
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
GWAS 后方法可识别 MS 风险背后的细胞特异性遗传途径
- 批准号:
9116321 - 财政年份:2014
- 资助金额:
$ 43.73万 - 项目类别:
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
GWAS 后方法可识别 MS 风险背后的细胞特异性遗传途径
- 批准号:
9330939 - 财政年份:2014
- 资助金额:
$ 43.73万 - 项目类别:
相似海外基金
Circuit mechanisms of arbitration between distinct reinforcement learning systems
不同强化学习系统之间的仲裁电路机制
- 批准号:
10608739 - 财政年份:2023
- 资助金额:
$ 43.73万 - 项目类别:
E-Arbitration: technological innovation, due process, and fairness in international commercial arbitration
电子仲裁:国际商事仲裁的技术创新、正当程序和公平性
- 批准号:
23K01164 - 财政年份:2023
- 资助金额:
$ 43.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MCA: Arbitration between cortical and subcortical control of behavior
MCA:皮层和皮层下行为控制之间的仲裁
- 批准号:
2317546 - 财政年份:2023
- 资助金额:
$ 43.73万 - 项目类别:
Standard Grant
Analysis of Process towards Amicable Settlement in the Proceedings of Arbitration or Mediation on International Business Disputes
国际商事纠纷仲裁或调解程序中的友好解决程序分析
- 批准号:
20K01319 - 财政年份:2020
- 资助金额:
$ 43.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MIDAS - Members of the Institute Data and Arbitration Services
MIDAS - 数据和仲裁服务协会成员
- 批准号:
84613 - 财政年份:2020
- 资助金额:
$ 43.73万 - 项目类别:
Collaborative R&D
Arbitration between habitual and goal-directed behavior in obsessive-compulsive disorder: circuit dynamics and effects of noninvasive neurostimulation
强迫症中习惯性行为和目标导向行为之间的仲裁:回路动力学和无创神经刺激的影响
- 批准号:
10841221 - 财政年份:2018
- 资助金额:
$ 43.73万 - 项目类别:
Arbitration between habitual and goal-directed behavior in obsessive-compulsive disorder: circuit dynamics and effects of noninvasive neurostimulation
强迫症中习惯性行为和目标导向行为之间的仲裁:回路动力学和无创神经刺激的影响
- 批准号:
10012942 - 财政年份:2018
- 资助金额:
$ 43.73万 - 项目类别:
Arbitration between habitual and goal-directed behavior in obsessive-compulsive disorder: circuit dynamics and effects of noninvasive neurostimulation
强迫症中习惯性行为和目标导向行为之间的仲裁:回路动力学和无创神经刺激的影响
- 批准号:
9789934 - 财政年份:2018
- 资助金额:
$ 43.73万 - 项目类别:
Arbitration between habitual and goal-directed behavior in obsessive-compulsive disorder: circuit dynamics and effects of noninvasive neurostimulation
强迫症中习惯性行为和目标导向行为之间的仲裁:回路动力学和无创神经刺激的影响
- 批准号:
10237896 - 财政年份:2018
- 资助金额:
$ 43.73万 - 项目类别:
The Social and Psychological Underpinnings of Commercial Arbitration in Europe
欧洲商业仲裁的社会和心理基础
- 批准号:
ES/R005664/1 - 财政年份:2018
- 资助金额:
$ 43.73万 - 项目类别:
Research Grant














{{item.name}}会员




